Projects per year
Fingerprint
Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy
Project: Research project
-
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy
9/1/11 → 8/31/16
Project: Research project
Research output
-
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Harrison, M. R., Costello, B. A., Bhavsar, N. A., Vaishampayan, U., Pal, S. K., Zakharia, Y., Jim, H. S. L., Fishman, M. N., Molina, A. M., Kyriakopoulos, C. E., Tsao, C. K., Appleman, L. J., Gartrell, B. A., Hussain, A., Stadler, W. M., Agarwal, N., Pachynski, R. K., Hutson, T. E., Hammers, H. J., Ryan, C. W. & 4 others, , Jul 1 2021, In: Cancer. 127, 13, p. 2204-2212 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Angiokines associated with targeted therapy outcomes in patients with non-clear cell renal cell carcinoma
Armstrong, A. J., Nixon, A. B., Carmack, A., Yang, Q., Eisen, T., Stadler, W. M., Jones, R. J., Garcia, J. A., Vaishampayan, U. N., Picus, J., Hawkins, R. E., Hainsworth, J. D., Kollmannsberger, C. K., Logan, T. F., Puzanov, I., Pickering, L. M., Ryan, C. W., Protheroe, A., George, D. J. & Halabi, S., Jun 2021, In: Clinical Cancer Research. 27, 12, p. 3317-3328 12 p.Research output: Contribution to journal › Article › peer-review
-
A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort
Patel, S. P., Mayerson, E., Chae, Y. K., Strosberg, J., Wang, J., Konda, B., Hayward, J., McLeod, C. M., Chen, H. X., Sharon, E., Othus, M., Ryan, C. W., Plets, M., Blanke, C. D. & Kurzrock, R., Sep 1 2021, In: Cancer. 127, 17, p. 3194-3201 8 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma
Lue, H. W., Derrick, D. S., Rao, S., Van Gaest, A., Cheng, L., Podolak, J., Lawson, S., Xue, C., Garg, D., White, R., Ryan, C. W., Drake, J. M., Ritz, A., Heiser, L. M. & Thomas, G. V., May 18 2021, In: Cell Reports Medicine. 2, 5, 100267.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
Patel, S. P., Othus, M., Chae, Y. K., Giles, F. J., Hansel, D. E., Singh, P. P., Fontaine, A., Shah, M. H., Kasi, A., Baghdadi, T. A., Matrana, M., Gatalica, Z., Korn, W. M., Hayward, J., McLeod, C., Chen, H. X., Sharon, E., Mayerson, E., Ryan, C. W., Plets, M. & 2 others, , May 15 2020, In: Clinical Cancer Research. 26, 10, p. 2290-2296 7 p.Research output: Contribution to journal › Article › peer-review
Open Access73 Scopus citations